Citation Impact
Citing Papers
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
2008
Conservative management of well-differentiated thyroid cancer.
2010
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
2008 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Theret/PTC Mutations Are Common in Sporadic Papillary Thyroid Carcinoma of Children and Young Adults1
2000
Diagnosis, treatment, and outcome of follicular thyroid carcinoma
1993
Solitary Thyroid Nodule: Diagnosis and Management
1988
Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging
2007
Clinical Course of Thyroid Carcinoma After Neck Dissection
2003
Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients
2004
Thyroid cancer
2016 Standout
Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children
2010
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer
2004
Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases
1994
Thyroid Carcinomas With Distant Metastases
2002
Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity*. Results from a prospective, randomized, multicentre study
1995
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
2000
Role of SPECT/CT in differentiated thyroid cancer
2012
A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems
2005
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Thyroid Remnant 131 I Ablation for Papillary and Follicular Thyroid Carcinoma
1997
THYROID CANCER IN CHILDREN, PREGNANT WOMEN, AND PATIENTS WITH GRAVES' DISEASE
1996
Pulmonary metastases in children and young adults with differentiated thyroid cancer
1993
Follicular Thyroid Carcinoma
2005
Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas
2002
Level VII is an Important Component of Central Neck Dissection for Papillary Thyroid Cancer
2013
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
2008 Standout
The Thyroid Nodule
2004 Standout
Serum Vascular Endothelial Growth Factor C Correlates With Lymph Node Metastases and High-Risk Tumor Profiles in Papillary Thyroid Carcinoma
2008
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
1994 Standout
Ipsilateral Versus Bilateral Central Neck Lymph Node Dissection in Papillary Thyroid Carcinoma
2009
Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake
2004
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Well-differentiated thyroid cancer
1994
The Value of Frozen Section Examinations in Determining the Extent of Thyroid Surgery in Patients With Indeterminate Fine-Needle Aspiration Cytology
2002
The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma
2006
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical131I Therapy in Both High- and Low-Risk Patients
2014
An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer
2008
Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children
2002
Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival
2014
Local control in differentiated thyroid carcinoma with extrathyroidal invasion
2000
Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study
2015
Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology?
2011
Percutaneous Ultrasound-Guided Laser Ablation Is Effective for Treating Selected Nodal Metastases in Papillary Thyroid Cancer
2012
A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism
2003
Accurate and Simple Method of Diagnosing Thyroid Nodules by the Modified Technique of Ultrasound-Guided Fine Needle Aspiration Biopsy
1995
Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas
2003 Standout
Changes in Clinical Presentation, Management and Outcome in 1348 Patients with Differentiated Thyroid Carcinoma: Experience in a Single Institute in Hong Kong, 1960–2000
2003
Contralateral Papillary Thyroid Cancer is Frequent at Completion Thyroidectomy with No Difference in Low- and High-Risk Patients
2001
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features
2002 Standout
Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma
2004
Changing concepts in the pathogenesis and management of thyroid carcinoma
1996
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
2005
Aggressive Papillary Thyroid Microcarcinoma
2012
Papillary and Follicular Thyroid Carcinoma
1998
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States
2004
Papillary Thyroid Carcinoma
1998
Microcarcinoma of the thyroid gland
1998
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
2002
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
2005
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
2010
Radioiodine Treatment with 30 mCi after Recombinant Human Thyrotropin Stimulation in Thyroid Cancer: Effectiveness for Postsurgical Remnants Ablation and Possible Role of Iodine Content inl -Thyroxine in the Outcome of Ablation
2003
Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinoma
2009
Surgical Management of the Patient with Papillary Cancer
1995
Graves' Ophthalmopathy
2010 Standout
Parathyroid Autotransplantation During Thyroidectomy
1996
Metastatic Minimally Invasive (Encapsulated) Follicular and Hurthle Cell Thyroid Carcinoma: A Study of 34 Patients
2000
Radioiodine Therapy for Multinodular Toxic Goiter
1999
Thyroid Cancer in Children
2007
The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart
2005
Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer
2004
Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
2007
Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer
2009
Differentiated Thyroid Carcinoma That Express Sodium-Iodide Symporter Have a Lower Risk of Recurrence for Children and Adolescents
2002
Minimal Extrathyroidal Extension in Patients with Papillary Thyroid Microcarcinoma: Is It a Real Prognostic Factor?
2011
Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas
2004
The impact of initial surgical management on outcome in young patients with differentiated thyroid cancer
1998
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma
2004
Clinical Presentations and Treatment for 74 Occult Thyroid Carcinoma
1996
Survival and Death Causes in Differentiated Thyroid Carcinoma
2006
Staging Systems for Papillary Thyroid Carcinoma
2007
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer
2013
Detection of Metastatic Cervical Lymph Nodes in Recurrent Papillary Thyroid Carcinoma
2009
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients
2011
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Subclinical Thyroid Disease
2004 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients
2012
Effects of low‐iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma
2003
Cervicomediastinal Magnetic Resonance Imaging in Persistent or Recurrent Papillary Thyroid Carcinoma: Clinical Use and Limits
1999
The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma
2005
Prospective multicenter study of thyroid carcinoma treatment
1998
Anaplastic thyroid carcinoma: Current diagnosis and treatment
2000
Prognostic Importance of Vascular Invasion in Papillary Thyroid Carcinoma
2000
The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents
2004
Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis
2012
Optimal treatment strategy in patients with papillary thyroid cancer: A decision analysis
2001
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Familial Nonmedullary Thyroid Carcinoma: A Meta-Review of Case Series
1997
Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
1996
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy
2002
Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma Patients
2007 Standout
Treatment for Microcarcinoma of the Thyroid—Clinical Experience
2007
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
2001
Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease
1995
Prognostic Nomograms To Predict Oncological Outcome of Thyroid Cancers
2013
Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer
2009
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
1998 Standout
Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH
2009
Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
1997
Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region
2009
Adverse aspects of small thyroid cancer and need for treatment
1995
Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma
2002
Incidental papillary microcarcinoma of the thyroid—factors affecting lymph node metastasis
2007
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma.
2008
Central cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging‐guided and prophylactic removal of the central compartment
2011
Overall and cause‐specific survival for patients undergoing lobectomy, near‐total, or total thyroidectomy for differentiated thyroid cancer
2010
Differentiated Thyroid Carcinoma in Pediatric Patients: Comparison of Presentation and Course between Pre-pubertal Children and Adolescents
2009
Differentiated Thyroid Cancer
1998
Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
2005
Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment
2004
Differentiated Thyroid Cancer: Determinants of Disease Progression in Patients <21 Years of Age at Diagnosis
1998
Treatment of Graves' disease and the course of ophthalmopathy
1989
Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma
1999
ROUTINE LEVEL VI LYMPH NODE DISSECTION FOR PAPILLARY THYROID CANCER: SURGICAL TECHNIQUE
2007
Staging Systems for Papillary Thyroid Carcinoma
2007
Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
2000
Role of Thyroglobulin Measurement in Fine-Needle Aspiration Biopsies of Cervical Lymph Nodes in Patients with Differentiated Thyroid Cancer
1999
Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope
2007
Update on Differentiated Thyroid Cancer Staging
2014
Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma
1998
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients
2008
Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long-term follow-up
1998
Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma
1998
Prognostic relevance of previous exposure to ionizing radiation in well-differentiated thyroid cancer
2003
Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes
1992
Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma
2006
Differentiated Thyroid Carcinoma in Children and Young Adults: Evaluation of Response to Treatment
2005
Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications
2004
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Thyroid cancer management
1995
Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer
2008
Diagnostic Accuracy of Conventional Versus Sonography-Guided Fine-Needle Aspiration Biopsy of Thyroid Nodules
1998
Benign and Malignant Thyroid Nodules: US Differentiation—Multicenter Retrospective Study
2008 Standout
In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy Is Associated with Significantly Worse Clinical Outcomes Than Only an Incomplete Thyroglobulin Response
2011
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Presurgical Serum Thyroglobulin Has No Prognostic Value in Papillary Thyroid Cancer
2005
Papillary Thyroid Carcinoma Patients Assessed to Be at Low or Intermediary Risk After Primary Treatment Are at Greater Risk of Long Term Recurrence If They Are Thyroglobulin Antibody Positive Or Do Not Have Distinctly Low Thyroglobulin at Initial Assessment
2011
BRAF Mutations are Uncommon in Papillary Thyroid Cancer of Young Patients
2005
The Effect of Methimazole on Cure Rates After Radioiodine Treatment for Graves' Hyperthyroidism: A Randomized Clinical Trial
2002
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Comparison with Published Systems of a New Staging System for Papillary and Follicular Thyroid Carcinoma
2012
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
Clinical Value of Different Responses of Serum Thyroglobulin to Recombinant Human Thyrotropin in the Follow-Up of Patients with Differentiated Thyroid Carcinoma
2005
False-Negative Fine-Needle Aspiration Cytology Results Delay Treatment and Adversely Affect Outcome in Patients with Thyroid Carcinoma
2004
Clinical Risk Factors Associated with Cervical Lymph Node Recurrence in Papillary Thyroid Carcinoma
2009
Characteristics of Follicular Cell-Derived Thyroid Carcinomas Occurring After External Radiation Exposure: Results of a Case Control Study Nested in a Cohort
2002
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Is Adjuvant Therapy Useful in Patients with Papillary Carcinoma Smaller Than 2 cm?
2007
A Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma: Clinical and Pathologic Features and Outcomes of 34 Consecutive Cases
2011
Clinical Comparison of Whole-Body Radioiodine Scan and Serum Thyroglobulin After Stimulation with Recombinant Human Thyrotropin
2002
The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008
2010
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults
1998
The Implication of Lymph Node Metastasis on Survival in Patients with Well-Differentiated Thyroid Cancer
2005
Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment
2002
Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996
2000
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
2000
Long-Term Results after Treatment of Very Low-, Low-, and High-Risk Thyroid Cancers in a Combined Setting of Thyroidectomy and Radio Ablation Therapy in Euthyroidism
2013
Does the method of management of papillary thyroid carcinoma make a difference in outcome?
1994
Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases
1999
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
1998
Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment
2002
Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy
1993
Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
1996
The incidence of bilateral well‐differentiated thyroid cancer found at completion thyroidectomy
1992
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Follicular and Hürthle cell carcinoma: Predicting outcome and directing therapy
1998
The Connection Between Art, Healing, and Public Health: A Review of Current Literature
2009 Standout
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.
1993
New Sonographic Criteria for Recommending Fine-Needle Aspiration Biopsy of Nonpalpable Solid Nodules of the Thyroid
2002 Standout
Modified Radical Neck Dissection for Differentiated Thyroid Cancer: Operative Technique
2004
Morbidity and mortality in follicular thyroid cancer.
1995
An Evidence‐based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow‐up
2007
Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma.
1994
Clinical prognostic index for recurrence of papillary thyroid carcinoma including intraoperative findings
2012
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Differentiated thyroid cancer long-term impact of initial therapy.
1995
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
2005
Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis
1999
Hypothyroidism in the Elderly*
1987
Prophylactic Central Neck Dissection and Local Recurrence in Papillary Thyroid Cancer: A Meta-analysis
2010
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
2013
Evaluating non-randomised intervention studies
2003 Standout
Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma.
1998
The Clinical and Economic Burden of a Sustained Increase in Thyroid Cancer Incidence
2013
Management of Low-Risk Differentiated Thyroid Cancer
2007
Factors that limit the quality, number and progress of randomised controlled trials.
1999
Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
1997
Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer
1994
Papillary Microcarcinoma: Is There Any Difference between Clinically Overt and Occult Tumors?
2006
Papillary microcarcinoma of the thyroid gland
1996
A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
2000
Optimal Surgery for Papillary Thyroid Carcinoma
1996
Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer: Towards A Selective Approach
1998
Application of Staging Systems for Differentiated Thyroid Carcinoma in an Endemic Goiter Region With Iodine Substitution
2003
Therapeutic Qualities of Clay-work in Art Therapy and Psychotherapy: A Review
2006
A comparison of different staging systems predictability of patient outcome
1997
Survival and Therapeutic Modalities in Patients with Bone Metastases of Differentiated Thyroid Carcinomas
2001
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.
1998
Cancer treatment and survivorship statistics, 2019
2019 Standout
Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?
1998
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Simplifying the TNM System for Clinical Use in Differentiated Thyroid Cancer
2009
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
2002
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
2005
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
2009
Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid Carcinoma
1998
The safety and efficacy of antithyroid drugs
2005
Impact of Initial Surgical Treatment on Survival of Patients with Differentiated Thyroid Cancer: Experience of an Endocrine Surgery Center in an Iodine‐deficient Region
2000
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
2007
Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
2004
Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer
2007
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
2004
Differentiated Thyroid Cancer: “Complete” Rational Approach
2000
Guidelines for the management of thyroid cancer
2014 Standout
Lateral and Mediastinal Lymph Node Dissection in Differentiated Thyroid Carcinoma: Indications, Benefits, and Risks
2007
Incidence of Regional Recurrence Guiding Radicality in Differentiated Thyroid Carcinoma
1996
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy
2012
Symptomatic versus Asymptomatic Papillary Thyroid Microcarcinoma: A Retrospective Analysis of Surgical Outcome and Prognostic Factors.
1999
An audit of management of differentiated thyroid cancer in specialist and non‐specialist clinic settings
2001
Prognosis of small thyroid cancer in patients with Graves' disease
2006
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade.
1995
Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma
1997
Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
1997
Thyroid carcinoma
2003 Standout
Impact of Prophylactic Central Neck Lymph Node Dissection on Early Recurrence in Papillary Thyroid Carcinoma
2010
Management of Graves' Ophthalmopathy: Reality and Perspectives
2000
Evaluation and Management of the Solid Thyroid Nodule
1995
Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome
1994
Works of Maureen McCormick being referenced
Sculpture: The Development of Three-Dimensional Representation in Clay
1995
Comparison of RA 131I treatment protocols for Graves’ disease
1990
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
1990 Standout
An empirical evaluation of the placebo run-in
1995
Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' Disease
1984
Graves' disease and thyroid cancer.
1986
Hürthle cell tumors: a twenty-five-year experience.
1986